Effect of brain-dead donor resuscitation on delayed graft function: Results of a monocentric analysis

Transplantation

Volumn 83, Issue 9, 2007, Pages 1174-1181

  Giral, Magali ^a   Bertola, Jean Pierre ^b   Foucher, Yohann ^c   Villers, Daniel ^b   Bironneau, Evelyne ^b   Blanloeil, Yvonnick ^b   Karam, Georges ^b   Daguin, Pascal ^a   Lerat, Lydie ^a   Soulillou, Jean Paul ^a  

^a INSERM   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

Brain death; Delayed graft function; Ischemia reperfusion; Kidney renal

Indexed keywords

ADRENALIN; HETASTARCH;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; BRAIN DEATH; CHILD; COLD ISCHEMIA; COLLOID; CORRELATION ANALYSIS; DELAYED GRAFT FUNCTION; DRUG USE; FEMALE; GRAFT RECIPIENT; GROUPS BY AGE; HUMAN; HYPERTENSION; INFUSION; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ORGAN DONOR; PRIORITY JOURNAL; RESUSCITATION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN DEATH; CHILD; CHILD, PRESCHOOL; COLD ISCHEMIA; DELAYED GRAFT FUNCTION; EPINEPHRINE; FEMALE; HETASTARCH; HUMANS; HYPERTENSION; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RESUSCITATION; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TIME FACTORS; TISSUE DONORS;

EID: 34248363183     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000259935.82722.11     Document Type: Article

References (42)

1. Giral-Classe M, Hourmant M, Cantarovich D, et al. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 1998; 54: 972.
2. Ojo AO, Wolfe RA, Held PJ, et al. Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968.
3. Feldman HI, Gayner R, Berlin JA, et al. Delayed function reduces renal allograft survival independent of acute rejection. Nephrol Dial Transplant 1996; 11: 1306.
4. Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation 1995; 59: 962.
5. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814.
6. Suri D, Meyer TW. Influence of donor factors on early function of graft kidneys. J Am Soc Nephrol 1999; 10: 1317.
7. Pessione F, Cohen S, Durand D, et al. Multivariate analysis of donor risk factors for graft survival in kidney transplantation. Transplantation 2003; 75: 361.
8. Ojo AO, Leichtman AB, Punch JD, et al. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis 2000; 36: 153.
9. Pratschke J, Wilhelm MJ, Kusaka M, et al. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 1999; 67: 343.
10. van den Eijnden MM, Leuvenink HG, Ottens PJ, et al. Effect of brain death and non-heart-beating kidney donation on renal function and injury: An assessment in the isolated perfused rat kidney. Exp Clin Transplant 2003; 1: 85.
11. van der Hoeven JA, Molema G, Ter Horst GJ, et al. Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys. Kidney Int 2003; 64: 1874.
12. Schnuelle P, Berger S, de Boer J, et al. Donor employment of vasopressors and its impact on allograft survival after transplantation. Transplant Proc 2001; 33: 1282.
13. Cittanova ML, Leblanc I, Legendre C, et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620.
14. Coronel B, Laurent V, Mercatello A, et al. [Can hydroxyethylamidon be used during intensive care of brain-dead organ donors?]. Ann Fr Anesth Reanim 1994; 13: 10.
15. Guesde R, Barrou B, Leblanc I, et al. Administration of desmopressin in brain-dead donors and renal function in kidney recipients. Lancet 1998; 352: 1178.
16. Irish WD, McCollum DA, Tesi RJ, et al. Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol 2003; 14: 2967.
17. Quiroga I, McShane P, Koo DD, et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006; 21: 1689.
18. Merkus JW, Hoitsma AJ, Koene RA. Detrimental effect of acute renal failure on the survival of renal allografts: influence of total ischaemia time and anastomosis time. Nephrol Dial Transplant 1991; 6: 881.
19. Carter JT, Chan S, Roberts JP, Feng S. Expanded criteria donor kidney allocation: Marked decrease in cold ischemia and delayed graft function at a single center. Am J Transplant 2005; 5: 2745.
20. Pinhero J, Bates D. Mixed-effects Models in S and S-plus. Springer 2000.
21. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351: 2715.
22. Opelz G, Dohler B. Cyclosporine and long-term kidney graft survival. Transplantation 2001; 72: 1267.
23. Vincenti F. A decade of progress in kidney transplantation. Transplantation 2004; 77 (9 Suppl): S52.
24. de Fijter JW, Mallat MJ, Doxiadis, II, et al. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 2001; 12: 1538.
25. Avihingsanon Y, Ma N, Pavlakis M, et al. On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. J Am Soc Nephrol 2005; 16: 1542.
26. Keith DS, Demattos A, Golconda M, et al. Effect of donor recipient age match on survival after first deceased donor renal transplantation.J Am Soc Nephrol 2004; 15: 1086.
27. Feduska NJ, Jr., Cecka JM. Donor factors. Clin Transpl 1994; 381.
28. Gourishankar S, Jhangri GS, Cockfield SM, Halloran PF. Donor tissue characteristics influence cadaver kidney transplant function and graft survival but not rejection. J Am Soc Nephrol 2003; 14: 493.
29. Zeier M, Dohler B, Opelz G, Ritz E. The effect of donor gender on graft survival. J Am Soc Nephrol 2002; 13: 2570.
30. Nyberg SL, Matas AJ, Rogers M, et al. Donor scoring system for cadaveric renal transplantation. Am J Transplant 2001; 1: 162.
31. Cosio FG, Qiu W, Henry ML, et al. Factors related to the donor organ are major determinants of renal allograft function and survival. Transplantation 1996; 62: 1571.
32. Cosio FG, Elkhammas EA, Henry ML, et al. Function and survival of renal allografts from the same donor transplanted into kidney-only or kidney-pancreas recipients. Transplantation 1998; 65: 93.
33. Gasser M, Waaga AM, Laskowski IA, Tilney NL. The influence of donor brain death on short and long-term outcome of solid organ allografts. Ann Transplant 2000; 5: 61.
34. Boom H, Mallat MJ, de Fijter JW, et al. Delayed graft function influences renal function, but not survival. Kidney Int 2000; 58: 859.
35. Schnuelle P, Gottmann U, Koppel H, et al. Comparison of early renal function parameters for the prediction of 5-year graft survival after kidney transplantation. Nephrol Dial Transplant 2007; 22: 235.
36. Schnuelle P, Berger S, de Boer J, et al. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation 2001; 72: 455.
37. Legendre C, Thervet E, Page B, et al. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993; 342: 248.
38. Kamar N, Garrigue V, Karras A, et al. Impact of early or delayed cyclosporine on delayed graft function in renal transplant recipients: A randomized, multicenter study. Am J Transplant 2006; 6: 1042.
39. Olyaei AJ, de Mattos AM, Bennett WM. Nephrotoxicity of immuno-suppressive drugs: new insight and preventive strategies. Curr Opin Crit Care 2001; 7: 384.
40. Ojo AO, Meier-Kriesche HU, Hanson JA, et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 2000; 69: 2405.
41. Remuzzi G, Lesti M, Gotti E, et al. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): A randomised trial. Lancet 2004; 364(9433): 503.
42. Pieringer H, Biesenbach G. Risk factors for delayed kidney function and impact of delayed function on patient and graft survival in adult graft recipients. Clin Transplant 2005; 19: 391.